Which laboratory studies are indicated for evaluating suspected hyperparathyroidism?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 24, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Laboratory Evaluation for Hyperparathyroidism

The essential laboratory workup for suspected hyperparathyroidism requires simultaneous measurement of serum calcium and PTH on the same blood sample, along with 25(OH) vitamin D, phosphorus, creatinine, and calculation of fractional excretion of calcium (FeCa) from spot or 24-hour urine collection 1, 2.

Core Diagnostic Labs (First-Line)

Blood Tests - Must Be Drawn Simultaneously

  • Serum calcium (total and/or ionized): Hypercalcemia is the hallmark finding
  • Intact PTH: Elevated or inappropriately "normal" (high-normal) in the setting of hypercalcemia confirms the diagnosis
  • 25(OH) vitamin D: Essential to exclude secondary hyperparathyroidism from vitamin D deficiency; must be normal (>20-30 ng/mL) for >6 months before diagnosing normocalcemic primary hyperparathyroidism 2
  • Phosphorus: Often low, though not specific
  • Creatinine: To assess renal function (calculate GFR)
  • Magnesium: Hypomagnesemia impairs PTH secretion and action; must be checked when PTH secretion is abnormal 2

Urine Tests

  • 24-hour urine calcium: Hypercalciuria (>300 mg/24h in men, >250 mg/24h in women) is typical 2
  • Fractional excretion of calcium (FeCa): This should be calculated for every suspected case - FeCa >2% indicates primary hyperparathyroidism and distinguishes it from familial hypocalciuric hypercalcemia (FHH) where FeCa ≤2% 2
    • Formula: FeCa = (urinary Ca × plasma creatinine)/(urinary creatinine × plasma Ca) × 100

Critical pitfall: PTH and calcium must be measured on the same blood sample to properly interpret their relationship 2. An elevated PTH with normal calcium on separate samples is meaningless.

Typical vs Atypical Presentations

Typical Primary Hyperparathyroidism (Grade A+++)

The diagnosis is straightforward when you find 2:

  • Hypercalcemia
  • Elevated PTH (or high-normal PTH, which is inappropriate with hypercalcemia)
  • FeCa >2%

Atypical Forms Requiring Additional Testing

Normocalcemic hyperparathyroidism (elevated PTH with normal calcium) requires:

  1. Rule out secondary causes first 1, 2:

    • Correct vitamin D deficiency and maintain normal levels for >6 months
    • Assess calcium intake (use dietary questionnaire)
    • Screen for malabsorption (bariatric surgery, chronic diarrhea)
    • Correct any identified causes before accepting the diagnosis

  2. Consider oral calcium loading test (Grade A+) 1, 2:

    • Collect 24-hour urine the day before
    • Fasting blood and urine samples at baseline
    • Administer 1 gram elemental calcium orally
    • Repeat blood and urine 2 hours post-loading
    • Positive test: Hypercalcemia develops, PTH fails to suppress, increased urinary calcium excretion

Hypercalcemia with "normal" PTH: The PTH is inappropriately normal for the calcium level - this still indicates primary hyperparathyroidism. Consider measuring ionized calcium when total calcium is borderline or upper-normal 2.

Assessment of Target Organ Damage (Grade A++)

Once diagnosis is confirmed, systematic evaluation is mandatory 1:

Renal Assessment

  • Serum creatinine with calculated GFR
  • 24-hour urine calcium (assess lithiasis risk)
  • Fasting calcium/creatinine ratio
  • Renal imaging: Low-dose CT scan (more sensitive than ultrasound) for kidney stones or nephrocalcinosis 1

Bone Assessment

  • Bone densitometry (DXA): Spine, femur, and radius
  • Consider spine X-rays or vertebral fracture assessment for asymptomatic fractures

Labs NOT Routinely Recommended

  • Bone turnover markers (alkaline phosphatase, osteocalcin): Not routinely measured in primary hyperparathyroidism 2
  • Urinary cyclic AMP: Research interest only, not clinically useful
  • Calcium/phosphorus ratio: While recent research suggests diagnostic utility 3, this is not yet incorporated into guideline recommendations

Common Pitfalls to Avoid

  1. Don't diagnose normocalcemic primary hyperparathyroidism without first correcting vitamin D deficiency for >6 months - this is the most common mistake 2

  2. Don't forget to calculate FeCa - it's essential for distinguishing primary hyperparathyroidism from FHH, which has completely different management 2

  3. Don't measure PTH and calcium on different days - the relationship between these values is what matters 2

  4. Don't overlook magnesium - hypomagnesemia can cause confusing PTH patterns 2

  5. Don't skip the 24-hour urine collection - urinary calcium is critical for assessing renal risk and calculating FeCa 1

References

2
Guideline

chapter 2: primary hyperparathyroidism: diagnosis.

Annales d'endocrinologie, 2025

Related Questions

Which laboratory tests should be monitored in hyperparathyroidism?
Is a parathyroid lab test typically included in a comprehensive metabolic panel (CMP) or endocrine panel?
How is hyperparathyroidism diagnosed and what are the treatment options?
What is hyperparathyroidism, including its definition, signs and symptoms, physical examination findings, and treatment options?
Which laboratory tests are most appropriate to assess calcium and phosphorus levels in a patient with hyperparathyroidism who is experiencing worsening lower‑leg neurological, atrophic, and motor symptoms?
What is the recommended way to take ferrous sulfate on an empty stomach, including appropriate dose, timing, and precautions?
In a morbidly obese patient with chronic atrial fibrillation on Eliquis (apixaban) who developed an unprovoked left popliteal deep vein thrombosis, is a hypercoagulable work‑up indicated?
What is the most efficient method to further characterize a bone lesion on plain radiographs beyond location, patient age, and radiographic transition zone?
Is a 20 mg dose of Vyvanse (lisdexamfetamine) causing decreased appetite and significant weight loss, and how should it be managed?
Can a patient safely take both Viibryd (vilazodone) and Savella (milnacipran) together?
For a patient with a laceration who is on thrice‑weekly hemodialysis, what is the appropriate antibiotic and dose?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.